Janssen Korea new CEO

Published: 2010-12-15 06:56:00

Updated: 2010-12-15 06:56:00

Janssen Korea says it has named Kim Sang-jin, CEO of Janssen Taiwan, to replace Choi Tai-hong. Kim will serve as CEO of Janssen Korea on Jan. 1, 2009.

Company officials said Kim was credited with his leadership in operating "CNS (central nervous system)" business unit after joining Janssen Kor...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK